DexCom Inc
I · AI-analyse
In het kort
DexCom designs and sells wearable glucose sensors that continuously measure blood sugar levels and send real-time data to a smartphone or receiver [Yahoo Finance]. Their core products include the Dexcom G7 and G6 systems for intensive diabetes management, Stelo for adults with prediabetes and Type 2 diabetes who don't use insulin, and the newly launched Dexcom Flex for Type 2 patients using basal insulin or oral medications [Yahoo Finance]. The company sells directly to doctors, endocrinologists, and diabetes educators in the U.S. and internationally [Yahoo Finance].
DexCom is a medical device company that makes continuous glucose monitoring (CGM) systems—wearable sensors that let people with diabetes check their blood sugar levels 24/7 without finger pricks [Yahoo Finance]. The company just announced a major 10-year growth plan promising at least 10% annual revenue growth through 2030, along with a $1 billion share buyback program [Yahoo Finance]. With $4.7 billion in revenue, strong profitability, and recent product launches like Dexcom Flex in Germany, the company is expanding access to CGM technology beyond insulin-dependent patients [Yahoo Finance].
DexCom is financially very healthy with strong profitability, no net debt, and excellent cash generation.
Sentinellis-score
10/10
Financieel gezond
Marktkapitalisatie
$25,8B
Omzet (12 maanden)
$4,7B
Uitleg
Hoe wij deze cijfers lezen
Begrijpelijke gidsen · geen account nodig
ROIC vs WACC Explained: How to Tell If a Company Actually Creates Value
What ROIC and WACC are, how to compute both, and why the spread between them is the single most important number in fundamental investing.
LezenPiotroski F-Score Explained: A 9-Point Financial Health Check (with a Live Apple Example)
What the Piotroski F-Score is, how to calculate all 9 criteria, and how to read the result. Plain English, with a real Apple walkthrough.
LezenAltman Z-Score Explained: Predicting Bankruptcy in 5 Minutes (with Real Examples)
What the Altman Z-Score is, the exact formula, how to read the result, and which version to use for manufacturers vs tech vs private companies.
LezenII · Recent nieuws
Wat de koers bewoog
6 berichten · gesorteerd op relevantie
- Macro2026-05-19
DXCM to Launch Dexcom Flex CGM System for Type 2 Diabetes in Germany
Yahoo Finance
- Macro2026-05-18
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo
Yahoo Finance
- Macro2026-05-18
Redefining CGM for People With Type 2 Diabetes: Dexcom Announces Dexcom Flex in Germany
Yahoo Finance
- Macro2026-05-16
DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day
Yahoo Finance
- Macro2026-05-17
Assessing DexCom (DXCM) Valuation After Investor Day Targets And New US$1b Buyback Plan
Simply Wall St
- Macro2026-05-17
Did New Long-Term Targets and US$1 Billion Buyback Just Shift DexCom's (DXCM) Investment Narrative?
Yahoo Finance
Premium · gratis met elk account
The stock has significantly underperformed the broader market over the past year, falling 28-34% while the S&P 500 rose 9-27%, suggesting investor concerns about growth or execution [Yahoo Finance].
Risico's
5
Kansen
6
Waarschuwingssignalen
1
Leiding
10
Nog 11 bevindingen in het volledige rapport — gratis met elk account.
Ontgrendel de volledige analyse van DexCom Inc
Maak een gratis account voor het volledige AI-rapport met bronvermelding in de tekst.
- 5 risico's, 6 kansen en 1 waarschuwingssignaal — elk met zijn bron
- Meer dan 100 financiële cijfers met grafieken en vergelijkingen
- Volledige nieuwssamenvattingen met bronlinks
- Directie en beloning
- PDF-export voor offline
III · Vergelijkbare bedrijven
Misschien ook interessant
Zelfde sector · Gezondheidszorg — of vergelijkbare financiële gezondheid
Op je volglijst zetten?